Article
Association of NPC1L1 and HMGCR gene polymorphisms with coronary artery calcification in patients with premature triple-vessel coronary disease.
BMC medical genomics - 17 Jan 2024
Li Yulong, Li Jiawen, Tang Xiaofang, Xu Jingjing, Liu Ru, Jiang Lin, Tian Jian, Zhang Yin, Wang Dong, Sun Kai, Xu Bo, Zhao Wei, Hui Rutai, Gao Runlin, Song Lei, Yuan Jinqing, Zhao Xueyan
Abstract excerpt
BACKGROUND: Coronary artery calcification (CAC) is a highly specific marker of atherosclerosis. Niemann-Pick C1-like 1 (NPC1L1) and 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) are the therapeutic targets of ezetimibe and statins, respectively, which are important for the progression of atherosclerosis. However, CAC's genetic susceptibility with above targets is still unknown. We aimed to investigate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
